Aqr Capital Management LLC Axsome Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 27,162 shares of AXSM stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,162

Previous 12,836 111.61%

Holding current value

$2.46 Million

Previous $1.03 Million 136.21%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$78.93 - $95.84 $1.13 Million - $1.37 Million	14,326 Added 111.61%	27,162 $2.44 Million
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $1.01 Million - $1.24 Million	-15,440 Reduced 54.6%	12,836 $1.03 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $1.38 Million - $1.95 Million	19,946 Added 239.45%	28,276 $2.26 Million
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $82,168 - $119,645	-1,431 Reduced 14.66%	8,330 $662,000
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $134,760 - $159,980	-1,946 Reduced 16.62%	9,761 $682,000
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $168,337 - $260,388	2,882 Added 32.66%	11,707 $841,000
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $8,641 - $11,100	148 Added 1.71%	8,825 $544,000
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $124,133 - $247,769	-3,108 Reduced 26.37%	8,677 $669,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $219,569 - $425,316	6,089 Added 106.9%	11,785 $526,000
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $123,831 - $266,288	5,696 New	5,696 $218,000
Q1 2021 May 17, 2021	SELL	$55.91 - $81.44 $378,734 - $551,674	-6,774 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $479,487 - $625,626	-7,231 Reduced 51.63%	6,774 $552,000
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $256,275 - $321,900	-3,750 Reduced 21.12%	14,005 $998,000
Q2 2020 Aug 17, 2020	SELL	$49.87 - $98.69 $181,028 - $358,244	-3,630 Reduced 16.97%	17,755 $1.46 Million
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $266,976 - $656,488	-6,480 Reduced 23.25%	21,385 $1.26 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $138,308 - $879,348	8,277 Added 42.26%	27,865 $2.88 Million
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $396,461 - $571,186	19,588 New	19,588 $396,000

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Axsome Therapeutics, Inc. Transaction History